University of Louisville, Clinical Trials Unit

Louisville, Kentucky 40202

4 studies enrolling now · 16 studies all time

What they study most

Atrial Fibrillation, COVID-19 Prevention, Chronic Abdominal Pain, Chronic Hepatitis Delta, Combined Pulmonary Fibrosis and Emphysema, Compensated Cirrhosis, Crohn's Disease, Epilepsies, Partial, Epilepsy, Epilepsy, Complex Partial, Epilepsy, Generalized, Fistulizing Crohn's Disease

Studies at this site

• Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus — Recruiting now
• Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis — Recruiting now
• Mirikizumab Real World Protocol — Recruiting now
• Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis — Running, not enrolling
• Gastric Electrical Stimulation for Abdominal Pain in Patients With Gastroparesis — Starting soon
• Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso — Completed
• Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease — Stopped early
• Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis — Completed
• Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC) — Completed
• Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE — Completed
• Safety, Tolerability, and Pharmacokinetics of Q-Griffithsin Intranasal Spray — Status unconfirmed
• Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease — Completed
• Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis — Completed
• Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Stopped early
• Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) — Completed
• Efficacy and Safety of Diazepam in the Management of Refractory Epilepsy in Selected Patients Who Require Intermittent Medical Intervention for Acute Repetitive Seizures. — Completed